The US state of Arkansas' legislature is considering three bills tolower prescription drug prices for seniors. One would allow seniors ineligible for Medicaid or without private drug cover to pay $25 to join a scheme overseen by the state Department of Human Services, and for which a federal waiver would be needed.
Under the plan, which its sponsor, Representative Jay Bradford, said should save seniors 25% of drug costs on average, drugmakers taking part in Medicaid would give the state a rebate for prescription drugs used by seniors on Medicaid. They would then pay a discounted price, arrived at by deducting the estimated rebate plus 10.5% from the average wholesale price. The pharmacist would still receive a dispensing fee.
The second bill seeks a study of prescription drug programs in other states, while the third would create a plan to help seniors find free or low-cost prescription drugs from manufacturers, reports the Associated Press.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze